The most common (≥20%) adverse reactions were fatigue, hypertension, diarrhea, decreased appetite, nausea, dysphonia, hypothyroidism, cough, and stomatitis, and the most common Grade 3 or 4 laboratory abnormalities (≥5%) were sodium decreased, lipase increased, and phosphate decreased.
from FDA,2021.03
Tivozanib: Rare but Serious Complications and Patient Safety StrategiesReversibl···【more】
Release date:2026-05-29Recommended:60
In-depth Analysis and Management of Tivozanib Side EffectsDuring treatment with ···【more】
Release date:2026-05-29Recommended:73
Recommended Dosage and Administration of TivozanibThe standard recommended dosag···【more】
Release date:2026-05-28Recommended:72
Hypertension-Related Warning for TivozanibThe most common serious side effect of···【more】
Release date:2026-05-28Recommended:69
Common Side Effects of Tivozanib and Daily Management StrategiesDuring treatment···【more】
Release date:2026-05-27Recommended:79